Symbols

XBIT

Xbiotech·NASDAQ

--(--)

XBIT Profile

Xbiotech Inc.

A biopharmaceutical company that discovers and develops True Human™ monoclonal antibodies for treating a variety of diseases

Industry

Pharmaceutical

Established Date

03/22/2005

Listing Date

04/15/2015

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.xbiotech.com

Security Type

Common stock

Office address

5217 Winnebago Ln, Austin, TX 78744

Business

Introduction

Xbiotech Inc., incorporated in Canada on March 22, 2005, is a clinical-stage biopharmaceutical company engaged in the discovery and cultivation of "true human" monoclonal antibodies for the treatment of a variety of diseases. XBiotech's true human monoclonal antibodies are derived from human donors capable of eliciting a natural human immune response.